Differential regulation of macrophage glucose metabolism by macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: Implications for 18F FDG PET imaging of vessel wall inflammation

Radiology

Volumn 283, Issue 1, 2017, Pages 87-97

  Tavakoli, Sina ^a   Short, John D ^b   Downs, Kevin ^a   Nguyen, Huynh Nga ^a   Lai, Yanlai ^a   Zhang, Wei ^a   Jerabek, Paul ^a   Goins, Beth ^a   Sadeghi, Mehran M ^c   Asmis, Reto ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b University of Texas Health Science Center   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; DEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER; GLYCOLYTIC ENZYME; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LACTIC ACID; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

ACIDIFICATION; AEROBIC METABOLISM; ANIMAL CELL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; AUTORADIOGRAPHY; BLOOD VESSEL WALL; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; EXTRACELLULAR SPACE; GENE OVEREXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; ISOTOPE LABELING; MACROPHAGE; METABOLIC REGULATION; METABOLITE; MITOCHONDRIAL BIOGENESIS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; ANIMAL; CELL DIFFERENTIATION; DIAGNOSTIC IMAGING; INFLAMMATION; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; FLUORODEOXYGLUCOSE F18; GLUCOSE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INFLAMMATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 85017170750     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2016160839     Document Type: Article

References (30)

1. Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol 2009;29(10):1419-1423.
2. Golestani R, Sadeghi MM. Emergence of molecular imaging of aortic aneurysm: implications for risk stratification and management. J Nucl Cardiol 2014;21(2):251-267; quiz 268-270.
3. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012;122(3):787-795.
4. Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res 2014;114(12):1867-1879.
5. Rominger A, Saam T, Wolpers S, et al. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med 2009;50(10):1611-1620.
6. Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48(9):1818-1824.
7. Marnane M, Merwick A, Sheehan OC, et al. Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol 2012;71(5):709-718.
8. Sadeghi MM. (18)F-FDG PET and vascular inflammation: time to refine the paradigm? J Nucl Cardiol 2015;22(2):319-324.
9. Tavakoli S, Zamora D, Ullevig S, Asmis R. Bioenergetic profiles diverge during macrophage polarization: implications for the interpretation of 18F-FDG PET imaging of atherosclerosis. J Nucl Med 2013;54(9):1661-1667.
10. Na YR, Hong JH, Lee MY, et al. Proteomic analysis reveals distinct metabolic differences between granulocyte-macrophage colony stimulating factor (GM-CSF) and macrophage colony stimulating factor (M-CSF) grown macrophages derived from murine bone marrow cells. Mol Cell Proteomics 2015; 14(10):2722-2732.
11. Izquierdo E, Cuevas VD, Fernández-Arroyo S, et al. Reshaping of human macrophage polarization through modulation of glucose catabolic pathways. J Immunol 2015;195(5): 2442-2451.
12. Tawakol A, Singh P, Mojena M, et al. HIF-1α and PFKFB3 mediate a tight relationship between proinflammatory activation and anerobic metabolism in atherosclerotic macrophages. Arterioscler Thromb Vasc Biol 2015; 35(6):1463-1471.
13. Tannahill GM, Curtis AM, Adamik J, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 2013;496 (7444):238-242.
14. Folco EJ, Sheikine Y, Rocha VZ, et al. Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. J Am Coll Cardiol 2011;58(6):603-614.
15. Lee SJ, Thien Quach CH, Jung KH, et al. Oxidized low-density lipoprotein stimulates macrophage 18F-FDG uptake via hypoxiainducible factor-1α activation through Nox2-dependent reactive oxygen species generation. J Nucl Med 2014;55(10):1699-1705.
16. Ogawa M, Nakamura S, Saito Y, Kosugi M, Magata Y. What can be seen by 18F-FDG PET in atherosclerosis imaging? The effect of foam cell formation on 18F-FDG uptake to macrophages in vitro. J Nucl Med 2012; 53(1):55-58.
17. Folco EJ, Sukhova GK, Quillard T, Libby P. Moderate hypoxia potentiates interleukin-1β production in activated human macrophages. Circ Res 2014;115(10):875-883.
18. Lacey DC, Achuthan A, Fleetwood AJ, et al. Defining GM-CSF- and macrophage-CSFdependent macrophage responses by in vitro models. J Immunol 2012;188(11):5752-5765.
19. Brochériou I, Maouche S, Durand H, et al. Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: implication in atherosclerosis. Atherosclerosis 2011; 214(2):316-324.
20. Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 2008;79(3):360-376.
21. Murayama T, Yokode M, Kataoka H, et al. Intraperitoneal administration of anti-c-fms monoclonal antibody prevents initial events of atherogenesis but does not reduce the size of advanced lesions in apolipoprotein E-deficient mice. Circulation 1999;99(13):1740-1746.
22. Subramanian M, Thorp E, Tabas I. Identification of a non-growth factor role for GM-CSF in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through IL-23 signaling. Circ Res 2015;116(2):e13-e24.
23. Ye P, Chen W, Wu J, et al. GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency. J Clin Invest 2013;123(5):2317-2331.
24. Son BK, Sawaki D, Tomida S, et al. Granulocyte macrophage colony-stimulating factor is required for aortic dissection/intramural haematoma. Nat Commun 2015;6:6994.
25. Elsegood CL, Chang M, Jessup W, Scholz GM, Hamilton JA. Glucose metabolism is required for oxidized LDL-induced macrophage survival: role of PI3K and Bcl-2 family proteins. Arterioscler Thromb Vasc Biol 2009;29(9):1283-1289.
26. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008;8(7):533-544.
27. Strehl C, Fangradt M, Fearon U, Gaber T, Buttgereit F, Veale DJ. Hypoxia: how does the monocyte-macrophage system respond to changes in oxygen availability? J Leukoc Biol 2014;95(2):233-241.
28. Vats D, Mukundan L, Odegaard JI, et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab 2006;4(1):13-24.
29. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol 2013;14(10):986-995.
30. Tarkin JM, Joshi FR, Rudd JH. PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol 2014;11(8):443-457.